HUMANA INC (HUM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 50B 100B 150B FY07: 25.3B FY08: 28.9B FY09: 30.7B FY10: 33.6B FY11: 36.8B FY12: 39.1B FY13: 41.3B FY14: 48.5B FY15: 54.3B FY16: 54.4B FY17: 53.8B FY18: 56.9B FY19: 64.9B FY20: 77.2B FY21: 83.1B FY22: 92.9B FY23: 106.4B FY24: 117.8B FY25: 129.7B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

0 2B 4B 6B FY07: 1.4B FY08: 1.1B FY09: 1.7B FY10: 1.9B FY11: 2.3B FY12: 2B FY13: 2.1B FY14: 2.4B FY15: 2.3B FY16: 1.7B FY17: 4.3B FY18: 3.1B FY19: 3.2B FY20: 5B FY21: 3.1B FY22: 3.8B FY23: 4B FY24: 2.6B FY25: 2.7B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 1.5B 3B 4.5B FY07: 833.7M FY08: 647.2M FY09: 1B FY10: 1.1B FY11: 1.4B FY12: 1.2B FY13: 1.2B FY14: 1.1B FY15: 1.3B FY16: 614M FY17: 2.4B FY18: 1.7B FY19: 2.7B FY20: 3.4B FY21: 2.9B FY22: 2.8B FY23: 2.5B FY24: 1.2B FY25: 1.2B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 6B 12B 18B FY07: 3.5B FY08: 3.9B FY09: 4B FY10: 4.4B FY11: 5.4B FY12: 5.8B FY13: 6.4B FY14: 7.6B FY15: 7.3B FY16: 7.2B FY17: 6.6B FY18: 7.5B FY19: 7.4B FY20: 10.1B FY21: 10.1B FY22: 12.7B FY23: 13.2B FY24: 13.7B FY25: 15.4B FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 2B 4B 6B FY07: 1.2B FY08: 982.3M FY09: 1.4B FY10: 2.2B FY11: 2.1B FY12: 1.9B FY13: 1.7B FY14: 1.6B FY15: 868M FY16: 1.9B FY17: 4.1B FY18: 2.2B FY19: 5.3B FY20: 5.6B FY21: 2.3B FY22: 4.6B FY23: 4B FY24: 3B FY25: 921M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 2B 4B 6B FY07: 985M FY08: 720.7M FY09: 1.2B FY10: 2B FY11: 1.7B FY12: 1.5B FY13: 1.3B FY14: 1.1B FY15: 345M FY16: 1.4B FY17: 3.5B FY18: 1.6B FY19: 4.5B FY20: 4.7B FY21: 920M FY22: 3.5B FY23: 3B FY24: 2.4B FY25: 375M FY07 FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 60M 120M 180M FY08: 169.2M FY09: 169.1M FY10: 169.8M FY11: 167.8M FY12: 163.5M FY13: 159.2M FY14: 155.9M FY15: 151.1M FY16: 150.9M FY17: 145.6M FY18: 138.4M FY19: 134.7M FY20: 133M FY21: 129.4M FY22: 127.1M FY23: 124.4M FY24: 120.9M FY25: 120.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 15.00 30.00 45.00 Q4 '08: 3.83 Q1 '09: 4.59 Q2 '09: 5.02 Q3 '09: 5.71 Q4 '09: 6.15 Q1 '10: 6.45 Q2 '10: 6.78 Q3 '10: 7.32 Q4 '10: 6.47 Q1 '11: 6.81 Q2 '11: 7.52 Q3 '11: 7.87 Q4 '11: 8.44 Q1 '12: 8.07 Q2 '12: 7.52 Q3 '12: 7.47 Q4 '12: 7.46 Q1 '13: 8.92 Q2 '13: 9.39 Q3 '13: 9.08 Q4 '13: 7.70 Q1 '14: 7.10 Q2 '14: 6.66 Q3 '14: 6.20 Q4 '14: 7.33 Q1 '15: 7.80 Q2 '15: 8.46 Q3 '15: 8.70 Q4 '15: 8.43 Q1 '16: 7.29 Q2 '16: 6.50 Q3 '16: 7.39 Q4 '16: 4.04 Q1 '17: 9.85 Q2 '17: 12.25 Q3 '17: 12.71 Q4 '17: 16.68 Q1 '18: 12.72 Q2 '18: 9.65 Q3 '18: 10.86 Q4 '18: 12.15 Q1 '19: 12.78 Q2 '19: 18.33 Q3 '19: 18.82 Q4 '19: 20.08 Q1 '20: 19.48 Q2 '20: 26.29 Q3 '20: 31.20 Q4 '21: 22.68 Q1 '22: 23.58 Q2 '22: 24.51 Q3 '22: 22.06 Q4 '22: 22.08 Q1 '23: 24.66 Q2 '23: 26.84 Q3 '23: 24.16 Q2 '10 Q1 '12 Q4 '13 Q3 '15 Q2 '17 Q1 '19 Q4 '21 Q3 '23

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.